Phase II study of sildenafil citrate in Waldenstrom's macroglobulinemia.

Trial Profile

Phase II study of sildenafil citrate in Waldenstrom's macroglobulinemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2011

At a glance

  • Drugs Sildenafil (Primary)
  • Indications Waldenstrom's macroglobulinaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
    • 20 Dec 2007 Status changed from in prgoress to discontinued.
    • 06 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top